Antonio Boldrini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Antonio Boldrini has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Paolo Ghirri
Santa Chiara University Hospital
2 shared publications - Amerigo Celandroni
Division of Pediatrics, – "F. Lotti" Hospital of Pontedera, Italy
1 shared publication - Angelo Baggiani
Department of Experimental Pathology, Medical Biotechnologies, Infectious Diseases and Epidemiology, University of Pisa, Pisa, Italy
1 shared publication - Annalisa Liumbruno
Division of ENT, Department of Neuroscience, University of Pisa, Pisa, Italy
1 shared publication - Carlotta Montagnani
Infectious Diseases Unit, Meyer Children's Hospital IRCCS, Florence, Italy
1 shared publication - Cinzia Magnani
University of Parma
1 shared publication
Latest Publications
- Open Access
- 1 February 2019
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 60 (1) , 105-107
Congenital tuberculosis after in vitro fertilization presenting with endobronchial granuloma
- 1 February 2019
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 60 (1) , 105-107
Open AccessCongenital tuberculosis after in vitro fertilization presenting with endobronchial granuloma
- Open Access
- 1 January 2011
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 37 (1) , 16
Universal neonatal audiological screening: experience of the University Hospital of Pisa
The early identification of pre-lingual deafness is necessary to minimize the consequences of hearing impairment on the future communication skills of a baby. According to the most recent international guidelines the deafness diagnosis must occur before the age of three months and the prosthetic-rehabilitative treatment with a traditional hearing aid should start within the first six months. When a Cochlear implant becomes necessary, the treatment should start between the age of 12 months and 18 months. The only way to diagnose the problem early is the implementation of universal neonatal audiological screening programs. Transient evoked otoacoustic emissions (TEOAE) is the most adequate test because it's accurate, economic and of simple execution. Automatic auditory brainstem response (AABR) is necessary to identify patients with auditory neuropathy but it is also important to reduce the number of false-positives.The 20-30% of infant hearing impairment is represented by progressive or late-onset hearing loss (HL) so it's also necessary to establish an audiological follow up program, especially in infants at risk.
- 1 January 2011
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 37 (1) , 16
Open AccessUniversal neonatal audiological screening: experience of the University Hospital of Pisa
The early identification of pre-lingual deafness is necessary to minimize the consequences of hearing impairment on the future communication skills of a baby. According to the most recent international guidelines the deafness diagnosis must occur before the age of three months and the prosthetic-rehabilitative treatment with a traditional hearing aid should start within the first six months. When a Cochlear implant becomes necessary, the treatment should start between the age of 12 months and 18 months. The only way to diagnose the problem early is the implementation of universal neonatal audiological screening programs. Transient evoked otoacoustic emissions (TEOAE) is the most adequate test because it's accurate, economic and of simple execution. Automatic auditory brainstem response (AABR) is necessary to identify patients with auditory neuropathy but it is also important to reduce the number of false-positives.The 20-30% of infant hearing impairment is represented by progressive or late-onset hearing loss (HL) so it's also necessary to establish an audiological follow up program, especially in infants at risk.
- Open Access
- 1 January 2009
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 35 (1) , 18
Prevalence of hypospadias in Italy according to severity, gestational age and birthweight: an epidemiological study
Hypospadias is a congenital displacement of the urethral meatus in male newborns, being either an isolated defect at birth or a sign of sexual development disorders. The aim of this study was to assess the prevalence rate of hypospadias in different Districts of Italy, in order to make a comparison with other countries all over the world. We reviewed all the newborns file records (years 2001–2004) in 15 Italian Hospitals. We found an overall hypospadias prevalence rate of 3.066 ± 0.99 per 1000 live births (82.48% mild hypospadias, 17.52% moderate-severe). In newborns Small for Gestational Age (birthweight < 10th percentile) of any gestational age the prevalence rate of hypospadias was 6.25 per 1000 live births. Performing multivariate logistic regression analysis for different degrees of hypospadias according to severity, being born SGA remained the only risk factor for moderate-severe hypospadias (p = 0.00898) but not for mild forms (p > 0.1). In our sample the prevalence of hypospadias results as high as reported in previous European and American studies (3–4 per 1000 live births). Pathogenesis of isolated hypospadias is multifactorial (genetic, endocrine and environmental factors): however, the prevalence rate of hypospadias is higher in infants born small for gestational age than in newborns with normal birth weight.
- 1 January 2009
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 35 (1) , 18
Open AccessPrevalence of hypospadias in Italy according to severity, gestational age and birthweight: an epidemiological study
Hypospadias is a congenital displacement of the urethral meatus in male newborns, being either an isolated defect at birth or a sign of sexual development disorders. The aim of this study was to assess the prevalence rate of hypospadias in different Districts of Italy, in order to make a comparison with other countries all over the world. We reviewed all the newborns file records (years 2001–2004) in 15 Italian Hospitals. We found an overall hypospadias prevalence rate of 3.066 ± 0.99 per 1000 live births (82.48% mild hypospadias, 17.52% moderate-severe). In newborns Small for Gestational Age (birthweight < 10th percentile) of any gestational age the prevalence rate of hypospadias was 6.25 per 1000 live births. Performing multivariate logistic regression analysis for different degrees of hypospadias according to severity, being born SGA remained the only risk factor for moderate-severe hypospadias (p = 0.00898) but not for mild forms (p > 0.1). In our sample the prevalence of hypospadias results as high as reported in previous European and American studies (3–4 per 1000 live births). Pathogenesis of isolated hypospadias is multifactorial (genetic, endocrine and environmental factors): however, the prevalence rate of hypospadias is higher in infants born small for gestational age than in newborns with normal birth weight.